Introduction {#sec1}
============

Hydroxyl amino acids are used as nutritional supplements in the food industry and as intermediates in the pharmaceutical industry. For example, *trans*-4-hydroxy-[l]{.smallcaps}-proline (*trans*-4-Hyp) is a major component of collagen and used as a nutritional supplement in animal diets in lieu of collagen.^[@ref1]^*trans*-4-Hyp has also been reported as a precursor for synthesis of pharmaceuticals and other important compounds, such as (−)-kainic acid,^[@ref2]^*N*-aryl pyrrole,^[@ref3]^ and the alkaloid TAN1251A.^[@ref4]^ Given that *trans*-4-Hyp has such a versatile use with high demand, efficient manufacturing methods that are environmental friendly are greatly needed. Similar situations, albeit less drastic, exist also for other hydroxyl amino acids. Compared with conventional methods involving tissue extraction and chemical synthesis,^[@ref5]^ biosynthesis has increasingly shown unique advantages of high specificity, low energy consumption, and low environmental pollution. For example, a 2-oxoglutarate (2-OG)-dependent dioxygenase can be used to synthesize *trans*-4-Hyp via [l]{.smallcaps}-proline hydroxylation simply with 2-OG, Fe(II), and dioxygen in the reaction ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Hydroxylation Reaction Catalyzed by *Ka*PH1](ao-2019-00983y_0001){#sch1}

2-OG-dependent dioxygenases for [l]{.smallcaps}-proline hydroxylation have been discovered in various microorganisms, such as *Dactylosporangium* sp. RH1,^[@ref6]^*Streptomyces griseoviridus* P8648,^[@ref7]^ and *Clonostachys cylindrospora* SANK 14591.^[@ref8]^ Among them, a 2-OG-dependent dioxygenase from *Dactylosporangium* sp. (P4H), which catalyzes *trans*-4-Hyp production, has previously been cloned into *Escherichia coli* (*E. coli*).^[@ref6]^ This P4H-expressing recombinant *E. coli* strain (W1485/pWFH1) was then cultured for 100 h in a jar fermenter, yielding 41 g·L^--1^*trans*-4-Hyp.^[@ref9]^ Although various 2-OG-dependent dioxygenases have been identified for biocatalytic conversion of [l]{.smallcaps}-proline to *trans*-4-Hyp, efficient enzymes with high selectivity are still limited, necessitating development or identification of a new dioxygenase.

The members of the 2-OG-dependent dioxygenase superfamily, such as clavaminic acid synthase^[@ref10]^ and arginine hydroxylase,^[@ref11]^ have similar reaction mechanisms due to characteristic amino acid residues. Thus, here we sought to identify a new 2-OG-dependent dioxygenase for [l]{.smallcaps}-proline hydroxylation by gene mining. We thereby identified a new Fe(II)- and 2-OG-dependent dioxygenase *Ka*PH1, which showed high [l]{.smallcaps}-proline hydroxylating activity. *Ka*PH1 was then cloned into an *E. coli* BL21(DE3) strain, expressed, and purified. The purified protein was used to characterize the catalytic activity of *Ka*PH1 for [l]{.smallcaps}-proline hydroxylation. Additionally, the unique biophysical features of *Ka*PH1 were predicted by molecular modeling whereby this study also contributes to our understanding of the catalytic mechanisms of 2-oxoglutarate-dependent dioxygenases.

Results and Discussion {#sec2}
======================

Gene Mining-Based Identification of Functional Dioxygenases {#sec2.1}
-----------------------------------------------------------

Hydroxylation of nonaromatic amino acids catalyzed by Fe(II)- and 2-OG-dependent dioxygenases, such as clavaminic acid synthase CAS^[@ref12]^ and [l]{.smallcaps}-arginine dioxygenase VioC,^[@ref13]^ occurs through a similar reaction mechanism. These two enzymes exhibit approximately 32% amino acid sequence identity. Thus, gene mining was performed based on sequence similarity. Toward this end, the amino acid sequence of P4H (GenBank: BAA20094.1) from *Dactylosporangium* sp. was used as the template whereby three putative functional proteins from *Kutzneria albida* (*K. albida*) were identified. Among these, *Ka*PH1 (GenBank: WP_025358137.1) exhibited 51% amino acid sequence identity to P4H, *Ka*PH2 (GenBank: WP_030110684.1) exhibited 45% amino acid sequence identity to P4H, and *Ka*PH3 (GenBank: WP_025355730.1) exhibited 42% amino acid sequence identity to P4H ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Sequence comparison among GriE, P4H, *Ka*PH1, *Ka*PH2, and *Ka*PH3. Gaps in the aligned sequences are indicated with dotted lines. Conserved amino acid residues are indicated in the blue box in which the same amino acid residues are shown with red background. Fe(II)- and 2-OG-binding residues are marked with triangles and circles, respectively. Predicted binding sites for [l]{.smallcaps}-proline and 2-OG are marked with rhombi and pentagons, respectively. Secondary structures are indicated for P4H as spirals (helices) and arrows. The multiple sequence alignment was generated by the ESPript program.](ao-2019-00983y_0008){#fig1}

Fe(II)/2-OG-dependent dioxygenases have a β-strand "jellyroll" structural fold that contains three metal-binding residues in a His-X-Asp/Glu-Xn-His motif.^[@ref14]^ Furthermore, 2-OG chelates Fe(II) with its C-2 keto group and C-1 carboxylate functions as the cofactor, while its C-5 carboxylate mediates an additional interaction with other side chains.^[@ref15]^ In consistency with this, His109, Asp111, and His215 of P4H are involved in metal binding. Additionally, an Arg residue residing at the active site of P4H (Arg226) is involved in 2-OG C-5 stabilization. Notably, the "His-X-Asp" carboxylate motif and Arg residue of the active site are conserved in *Ka*PH1, *Ka*PH2, and *Ka*PH3. The structural similarity between the active site of P4H and that of *Ka*PH1, *Ka*PH2, and *Ka*PH3 suggested that the three proteins may catalyze [l]{.smallcaps}-proline hydroxylation.

The corresponding genes encoding *Ka*PH1, *Ka*PH2, *Ka*PH3, and P4H were cloned and expressed in recombinant *E. coli*. The recombinants were cultured in autoinduction media at 20 °C. As shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a, all the enzymes were heterologously expressed in soluble forms. Additionally, they all showed distinct bands in SDS-PAGE in agreement with the predicted molecular weights (P4H, 29.71 kDa; *Ka*PH1, 29.02 kDa; *Ka*PH2, 29.48 kDa; *Ka*PH3, 30.1 kDa).

![Expression of the dioxygenases and their catalytic activities on [l]{.smallcaps}-proline. (a) Heterologous expression of recombinant enzymes induced at 20 °C. M: molecular weight standards (Bio-Rad). Lanes 1 and 2: the total protein and soluble fraction of P4H; lanes 3and 4: the total protein and soluble fraction of *Ka*PH1; lanes 5 and 6: the total protein and soluble fraction of *Ka*PH2; lanes 7 and 8: the total protein and soluble fraction of *Ka*PH3. (b) Production of *trans*-4-Hyp in the growth phase of the recombinant strains. These recombinants were cultivated in autoinduction media containing 20 mM [l]{.smallcaps}-proline as the substrate. The *trans*-4-Hyp content of the fermentation supernatant was measured under standard conditions.](ao-2019-00983y_0003){#fig2}

The catalytic activities of the recombinant proteins for [l]{.smallcaps}-proline hydroxylation were further evaluated with 20 mM [l]{.smallcaps}-proline as the substrate. The products were isolated and subjected to structural analysis as described above. The spectra of ^1^H NMR ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00983/suppl_file/ao9b00983_si_001.pdf)), ^13^C NMR ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00983/suppl_file/ao9b00983_si_001.pdf)), and MS ([Figure S4a](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00983/suppl_file/ao9b00983_si_001.pdf)) are shown in the Supporting Information. As shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b, 2223 mg·L^--1^ of *trans*-4-Hyp was produced in the growth phase of the recombinant strain *Ka*PH1, with a yield of 84.8%, while 2022 mg·L^--1^*trans*-4-Hyp was achieved in the growth phase by P4H with a yield of 77.1%. The yields obtained from recombinant strains *Ka*PH2 and *Ka*PH3 were 64.8% (1723 mg·L^--1^) and 54.7% (1455 mg·L^--1^), respectively. No significant difference was observed in the OD~600~ values of the recombinants, suggesting that growth of the recombinants is normal. The results indicated that the recombinant *E. coli* strain *Ka*PH1 derived from gene mining showed a relatively high [l]{.smallcaps}-proline hydroxylating activity compared with P4H. Therefore, *Ka*PH1 was further processed by affinity purification.

Kinetic Parameters of *Ka*PH1 {#sec2.2}
-----------------------------

The Michaelis--Menten kinetic parameters of *Ka*PH1 and P4H were measured by varying [l]{.smallcaps}-proline and 2-OG concentrations. Comparisons of the kinetic parameters are shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. The *k*~cat~ value of *Ka*PH1 for [l]{.smallcaps}-proline was 1.47 times higher than that of P4H, while the *K*~m~ value of *Ka*PH1 was slightly higher than that of P4H. The *k*~cat~ value of *Ka*PH1 for 2-OG was higher than that of P4H with a lower *K*~m~ value. Although P4H had a higher affinity for [l]{.smallcaps}-proline than *Ka*PH1, the reaction rate of *Ka*PH1 was 1.47 times higher than that of P4H with a higher affinity and higher reaction rate for 2-OG. The *k*~cat~/*K*~m~ values of *Ka*PH1 for both substrates were higher than those of P4H, indicating that *Ka*PH1 would be favorable for [l]{.smallcaps}-proline hydroxylation that involves 2-OG decarboxylation.

###### Kinetics Data Collected for P4H and *Ka*PH1 with [l]{.smallcaps}-Proline

  enzyme    substrate                 *K*~m~ (mM)   *V*~max~ (μM·min^--1^·mg^--1^)   *k*~cat~ (s^--1^)   *k*~cat~/*K*~m~ (s^--1^·mM^--1^)
  --------- ------------------------- ------------- -------------------------------- ------------------- ----------------------------------
  P4H       [l]{.smallcaps}-proline   1.00 ± 0.07   0.76 ± 0.04                      0.38 ± 0.02         0.37 ± 0.02
  2-OG      1.35 ± 0.04               0.92 ± 0.05   0.45 ± 0.01                      0.34 ± 0.07         
  *Ka*PH1   [l]{.smallcaps}-proline   1.07 ± 0.11   1.12 ± 0.06                      0.54 ± 0.01         0.51 ± 0.05
  2-OG      0.84 ± 0.10               1.03 ± 0.09   0.50 ± 0.02                      0.59 ± 0.05         

To elucidate the biophysical differences between P4H and *Ka*PH1, homology modeling, and molecular docking analyses were performed. The leucine dioxygenase GriE (PDB: 5NCI) as the highest scoring template was submitted for the prediction of potential binding sites of *Ka*PH1 and P4H. It exhibits 41.34 and 41.9% identity to *Ka*PH1 and P4H, respectively. The structural alignment was performed as shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a. The active center of *Ka*PH1 (purple) almost coincides with that of P4H (green). Notably, the residues (Glu150-Asp183) of P4H form a rigid α-helix near the HXD/E···H Fe(II)-binding motif, while the residues (Leu150-Leu183) of *Ka*PH1 form flexible loops. Both components are probably important in the conversion of [l]{.smallcaps}-proline, causing the difference in the catalytic performance between P4H and *Ka*PH1. Additionally, the crystal structures of GriE showed conformational changes in the loop regions of which the loop comprising residues 159--176 was assumed to be a lid for the active site.^[@ref16]^

![Biophysical analysis of the dioxygenases. (a) Structural alignment of *Ka*PH1 and P4H. The model of *Ka*PH1 and P4H is displayed in purple and green, respectively. Molecular docking results of 2-OG and substrate [l]{.smallcaps}-proline in (b) *Ka*PH1 and (c) P4H. The distances between C4 of [l]{.smallcaps}-proline/C1 of 2-OG and Fe(II) are illustrated by yellow dashed lines.](ao-2019-00983y_0007){#fig3}

Furthermore, Fe(II), 2-OG, and [l]{.smallcaps}-proline were docked into the active center of *Ka*PH1 and P4H using AutoDock. The distance between [l]{.smallcaps}-proline and Fe(II) as well as 2-OG were calculated and illustrated in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b,c. The Fe(II) is bound with three residues (His109, Asp111, and His211/215) in the docking models, while 2-OG binds to the Fe(II) with the C-1 carboxylate and C-2 ketone, and its C-5 carboxylate interacts with another residue (Arg222/226) for additional structural stabilization. The side chains of three residues (His109, Asp111, and His211/215), Gln92, and Trp115 are neatly arranged near Fe(II). Among them, Gln92 and Trp115 may interact with the proline carboxylate, properly positioning proline with the C4 bond for oxidation with respect to Fe(II).^[@ref15]^ Next, the side chains of three residues (Asn96, Ser 213/217, and Arg222/226) may help the carbonyl group of 2-OG to position toward the Fe(II). Conformation of the active site that contains Fe(II) and [l]{.smallcaps}-proline converts to a Fe(IV)-peroxyhemiketal transition state as dioxygen binds to the vacant coordination site and interacts with the carbonyl group of 2-OG.^[@ref16]^ Afterward, 2-OG is decarboxylated followed by hydroxylation of [l]{.smallcaps}-proline.^[@ref17]^ Notably, the distance between C4 of [l]{.smallcaps}-proline and Fe(II) is 3.8 Å in the active center of *Ka*PH1, while it is 5.7 Å with P4H. The distance between C1 of 2-OG and Fe(II) in the active center of *Ka*PH1 (2.5 Å) is shorter than that with P4H (2.6 Å). The proximity may lead to a higher catalytic efficiency in *Ka*PH1 toward the substrate/cofactor. Molecular modeling analysis suggested that the structures of *Ka*PH1 and P4H are similar, especially in the conserved motif. The structural differences in flexibility and interaction with metals and substrates are expected to influence the catalytic activities of the enzymes.

Effects of Temperature and pH on *Ka*PH1 Activity {#sec2.3}
-------------------------------------------------

2-OG-dependent dioxygenases specific for [l]{.smallcaps}-proline hydroxylation from various microbial strains exhibit an optimum temperature range of 30--40 °C and pH range of 6.0--7.5.^[@ref18]^ The effects of temperature and pH on the catalytic activity of recombinant *Ka*PH1 were investigated. The relative activity of recombinant *Ka*PH1 was maintained above 60% at a temperature range of 20--35 °C and reached the maximum activity at 30 °C ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a). According to the pH profile ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b), *Ka*PH1 showed the highest activity around pH 6.5 in the MES buffer (0.05 M) with an abrupt increase at pH 6.0, and it was stable under slightly acidic conditions.

![Effects of temperature and pH on the activity of *Ka*PH1. (a) Optimum temperature of [l]{.smallcaps}-proline hydroxylation by *Ka*PH1. (b) Optimum pH of [l]{.smallcaps}-proline hydroxylation by *Ka*PH1. The following buffers were used: MES--Tris buffer (0.05 M), pH 4--7.0; Tris--HCl buffer (0.05 M), pH 7.0--9.0. The maximum *Ka*PH1 enzymatic activity was set to 100%.](ao-2019-00983y_0006){#fig4}

Effects of Common Cofactors and Inhibitors on the Enzymatic Activity {#sec2.4}
--------------------------------------------------------------------

The effects of several common enzymatic cofactors and inhibitors on the enzyme activity were investigated in the activity assay system. As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, the requirement of 2-OG appeared to be very strict, and no *trans*-4-Hyp was detected without 2-OG. This phenomenon has also been found in other 2-OG-dependent dioxygenases with 2-OG as the decarboxylation cosubstrate.^[@ref19]^

###### . Effects of Common Cofactors and Inhibitors on the Enzymatic Activity

  components              compounds[a](#t2fn1){ref-type="table-fn"}   concn (mM)   relative activity (%)
  ----------------------- ------------------------------------------- ------------ -----------------------
  Pro, Fe(II), 2-OG, VC   none                                        0            100
  Pro, Fe(II), VC         none                                        0            0
  Pro, 2-OG, VC           none                                        0            14
  Pro, Fe(II), 2-OG       none                                        0            69
  Pro, Fe(II), 2-OG, VC   EDTA                                        4            3
  Pro, Fe(II), 2-OG, VC   1,10-phenanthroline                         4            2
  Pro, Fe(II), 2-OG, VC   diethyl pyrocarbonate                       4            0
  Pro, Fe(II), 2-OG, VC   MgSO~4~                                     2            82
  Pro, Fe(II), 2-OG, VC   MnCl~2~                                     2            79
  Pro, Fe(II), 2-OG, VC   CoCl~2~                                     2            22
  Pro, Fe(II), 2-OG, VC   ZnSO~4~                                     2            12
  Pro, Fe(II), 2-OG, VC   CuSO~4~                                     2            14
  Pro, Fe(II), 2-OG, VC   NiSO~4~                                     2            7

Effects of chemicals and metal ions were assayed under standard assay conditions. Relative activity was calculated as percentages to the enzymatic activity under the following conditions: [l]{.smallcaps}-proline (Pro, 10 mM), 2-oxoglutarate (2-OG, 10 mM), ferrous sulfate (Fe(II), 1.5 mM), [l]{.smallcaps}-ascorbic acid (VC, 10 mM).

The 2-OG-dependent dioxygenases are likely to have the relevant structural feature where the Asp and two His residues are conserved.^[@ref20]^ As a selective His-modifying reagent,^[@ref21]^ the effect of diethyl pyrocarbonate on the enzymatic activity of *Ka*PH1 was investigated. Complete inhibition of the enzymatic activity of *Ka*PH1 was detected with 4 mM diethyl pyrocarbonate, suggesting that the His residues are critical for *Ka*PH1's enzymatic activity. [l]{.smallcaps}-ascorbate was reported to be involved in biochemical reactions catalyzed by dioxygenases that require Fe(II) and 2-OG as cofactors,^[@ref22]^ and thus, as expected, [l]{.smallcaps}-ascorbate promoted *Ka*PH1 activity. Furthermore, EDTA and 1,10-phenanthroline as the chelating agents strongly inhibited the enzymatic activity, suggesting the requirement for Fe(II). [l]{.smallcaps}-proline hydroxylating activity of *Ka*PH1 without FeSO~4~ in the reaction mixture is presumably due to *Ka*PH1's interaction with the Fe(II) pool of the *E. coli* cells before the purification, as reported previously.^[@ref23]^

Inhibition of 2-OG dioxygenases by divalent transition metal ions has been extensively observed. Mn^2+^, Ni^2+^, Co^2+^, Cu^2+^, and Zn^2+^ were generally found to be the most potent inhibitors.^[@ref24]^ The enzymatic activity of *Ka*PH1 declined in the presence of divalent transition metal ions ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), and the strongest inhibition was caused by Zn^2+^, Ni^2+^, Co^2+^, and Cu^2+^. Inhibition is mostly attributed to competition with Fe(II) for binding to the active site, although such competition was observed at nonactive sites in some cases as well.^[@ref25]^

Enzymatic Activity toward [l]{.smallcaps}-Isoleucine {#sec2.5}
----------------------------------------------------

Besides *trans*-4-Hyp, 4-HIL is another major hydroxyl amino acid constituent of important pharmaceuticals.^[@ref26],[@ref27]^ It can be synthesized via [l]{.smallcaps}-isoleucine hydroxylation by 2-OG-dependent dioxygenases.^[@ref28]^[l]{.smallcaps}-Isoleucine is an aliphatic amino acid and thus differs from [l]{.smallcaps}-proline, which has a heterocyclic structure. Therefore, [l]{.smallcaps}-isoleucine hydroxylation activity of *Ka*PH1 was also evaluated under standard conditions. The reaction mixture was subjected to HPLC analysis as described above. As shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}, *Ka*PH1 was active toward [l]{.smallcaps}-isoleucine. The products were characterized by ^1^H NMR spectroscopy ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00983/suppl_file/ao9b00983_si_001.pdf)) and MS ([Figure S4b](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00983/suppl_file/ao9b00983_si_001.pdf)). These results indicate that *Ka*PH1 can hydroxylate different amino acids whereby the most useful intermediates for food and pharmaceutical industries are produced.

![[l]{.smallcaps}-Isoleucine hydroxylation by *Ka*PH1. *trans*-4-Hyp was detected by LC--MS analysis after the incubation of *Ka*PH1 with [l]{.smallcaps}-proline ([l]{.smallcaps}-Pro) as the substrate. 4-HIL was detected by LC--MS analysis after the incubation of *Ka*PH1 with [l]{.smallcaps}-isoleucine (L-Ile) as the substrate. Relative activities are presented with the assumption that the activity on [l]{.smallcaps}-Pro is 100%. 4-HIL was further characterized by MS and ^1^H NMR as described in the ESI.](ao-2019-00983y_0005){#fig5}

[l]{.smallcaps}-Proline Hydroxylation by *Ka*PH1 {#sec2.6}
------------------------------------------------

Hydroxylation of [l]{.smallcaps}-proline, with the concentration of 10--120 mM, was catalyzed by 1 g·L^--1^ purified *Ka*PH1 in 10--210 min. As shown in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}, *Ka*PH1 showed a robust catalytic activity for [l]{.smallcaps}-proline hydroxylation, completely converting 10 mM [l]{.smallcaps}-proline within 10 min. Substrate inhibition was not evident during the hydroxylation reaction under any substrate concentration. In addition, *Ka*PH1 generated 92.8% *trans*-4-Hyp yield with 120 mM [l]{.smallcaps}-proline after 4 h (3.93 g·L^--1^·h^--1^). P4H-containing recombinant *E. coli* W1485/pWFH1 yielded 41 g·L^--1^ of *trans*-4-Hyp after 100 h of culturing.^[@ref9]^ Bontoux et al.^[@ref100]^ evaluated five strains of *Clonostachys cylindrospora* that produce *trans*-4-Hyp. Among these, SANK 14591 generated *trans*-4-Hyp with a yield of 13.8 mg·L^--1^.^[@ref8]^ By comparison, *Ka*PH1 would be a highly efficient biocatalyst for in vitro enzymatic generation of *trans*-4-Hyp.

![[l]{.smallcaps}-Proline hydroxylation catalyzed by the recombinant *Ka*PH1. Samples were taken every 10 min, and the content of *trans*-4-Hyp was measured under standard conditions.](ao-2019-00983y_0002){#fig6}

Conclusions {#sec3}
===========

In this paper, three putative dioxygenases from *K. albida* were identified by gene mining against P4H. By evaluating the [l]{.smallcaps}-proline hydroxylation capacity of the putative enzymes, a new Fe(II)- and 2-OG-dependent dioxygenase *Ka*PH1 from *K. albida* was identified and characterized for its efficiency in converting free [l]{.smallcaps}-proline to *trans*-4-Hyp. Furthermore, the findings demonstrated the high biotransformation efficiency of *Ka*PH1 (a 92.8% yield when 120 mM [l]{.smallcaps}-proline was used as the substrate) as well as its [l]{.smallcaps}-isoleucine hydroxylation activity. In conclusion, the newly identified enzyme *Ka*PH1 is a promising biocatalyst for in vitro generation of *trans*-4-Hyp and other hydroxyl amino acids.

Materials and Methods {#sec4}
=====================

Materials {#sec4.1}
---------

A *Kutzneria albida* CGMCC 4.1347 strain was obtained from the China General Microbiological Culture Collection Center (CGMCC, Beijing, China). An *E. coli* BL21(DE3) strain was used for the gene expression. The plasmid pET-28a was obtained from Novagen (U.S.A.) and served as the expression vector. All the enzymes for the genetic manipulations were purchased from Takara Biotechnology Co., Ltd. (Dalian, China). The standard samples of *trans*-4-Hyp and *cis*-4-Hyp were purchased from Cambridge Sigma-Aldrich (Munich, Germany). Unless otherwise stated, all the other chemicals were purchased from Sinopharm Chemical Reagent Company (Shanghai, China).

Candidate Gene Screening and Sequence Analysis {#sec4.2}
----------------------------------------------

To identify potential dioxygenases for [l]{.smallcaps}-proline hydroxylation, we searched the National Center for Biotechnology Information database (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) using the amino acid sequence of P4H as the query in the protein BLAST algorithm (GenBank accession number: BAA20094.1).^[@ref29]^ Multiple sequence alignments with secondary structure elements were generated by ESPript.^[@ref30]^

Cloning of the Candidate Dioxygenase Genes {#sec4.3}
------------------------------------------

The genes encoding the potential dioxygenases with 42--51% homology to P4H were amplified from the *K. albida* genome using appropriate primer pairs containing the *Nde*I/*Hind*III and *Xho*I restriction sites ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). As a control, the P4H gene (GenBank accession number: D78338) was synthesized by the Ruidi Biotech Company (Shanghai, China). The purified fragments were digested with the abovementioned restriction enzymes and ligated into the pET-28a expression vector. Next, verified recombinant plasmids were transformed into *E. coli* BL21 (DE3) competent cells.

###### Strains/Plasmids/Primers Used in this Study

  strains/plasmids/primers          features                                 source
  --------------------------------- ---------------------------------------- ------------
  *Kutzneria albida* CGMCC 4.1347   origin for potential genes               CGMCC
  pET-28a-P4H                       pET-28a containing P4H                   this study
  pET-28a-*Ka*PH1                   pET-28a containing *Ka*PH1               this study
  pET-28a-*Ka*PH2                   pET-28a containing *Ka*PH2               this study
  pET-28a-*Ka*PH3                   pET-28a containing *Ka*PH3               this study
  F-*Ka*PH1                         5′-TGCATCATATGCTCACCGATTCGCAGT-3′        
  R-*Ka*PH1                         5′- TTAAGCTTTCATGCGCCCAGGC-3′            
  F-*Ka*PH2                         5′-CAAGCTTGGCTGATGACTGACACCGCACT-3′      
  R-*Ka*PH2                         5′-CCTCGAGGGGGTCAGACGGACAGCGC-3′         
  F-*Ka*PH3                         5′-CAAGCTTGGACCATGCGTTTGAACGACAAGCA-3′   
  R-*Ka*PH3                         5′- CCTCGAGGGCTCATGCCGACACCTGGC-3′       

Bacterial Culture and Recombinant Gene Expression {#sec4.4}
-------------------------------------------------

Recombinant *E. coli* BL21(DE3) strains were grown at 37 °C in LB liquid medium containing 50 μg·mL^--1^ kanamycin. Cells were inoculated into 30 mL of autoinduction media (tryptone, 10 g·L^--1^; yeast extract, 5 g·L^--1^; glycerol, 5 g·L^--1^; glucose, 0.5 g·L^--1^; α-lactose, 10 g·L^--1^; Na~2~HPO~4~, 7.1 g·L^--1^; KH~2~PO~4~, 6.8 g·L^--1^; NH~4~Cl, 2.68 g·L^--1^; Na~2~SO~4~, 0.71 g·L^--1^; MgSO~4~·7H~2~O, 0.74 g·L^--1^; CaCl~2~, 0.015 g·L^--1^; pH 7.0).^[@ref31]^ Cultures were grown in baffled Erlenmeyer flasks on rotary shakers. Cell densities were monitored by measuring the optical density at 600 nm (OD~600~) using a A380 scanning UV--vis spectrophotometer (AOE Instruments Company, Shanghai, China). Recombinant protein production was analyzed by sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS-PAGE).^[@ref32]^ Digital images of the gels were captured on a Gel Doc 2000 instrument (Bio-Rad, Shanghai, China).

Identification of Functional Dioxygenases Catalyzing [l]{.smallcaps}-Proline Hydroxylation {#sec4.5}
------------------------------------------------------------------------------------------

The recombinant strains were inoculated into the whole cell conversion system where glucose (20 mM), [l]{.smallcaps}-proline (20 mM), [l]{.smallcaps}-ascorbic acid (5 mM), 2-OG (20 mM), FeSO~4~·7H~2~O (0.5 mM), MgSO~4~ (2 mM), and CaCl~2~ (0.5 mM) were added into 30 mL of autoinduction media. The recombinant strains were first cultured at 37 °C, 200 rpm for 3 h, and then incubated at 20 °C, 250 rpm for 96 h for whole cell conversion. Samples were taken every 12 h. They were boiled for 10 min, centrifuged at 18,514 × *g* for 10 min at 4 °C, and the supernatant was analyzed by high-performance liquid chromatography (HPLC)^[@ref33]^ whereby *trans*-4-Hyp was detected.

Protein Purification {#sec4.6}
--------------------

The crude enzymes were obtained after disruption of the bacterial pellet and centrifugation, and the supernatant was purified using a HisTrap HP affinity column (GE Healthcare, U.S.A.).^[@ref34]^ Then, the purified fractions were applied to disposable PD-10 desalting columns (GE Healthcare, U.S.A.) to remove the high salt content derived from the elution buffer of the affinity columns.^[@ref35]^ The protein yields were evaluated by a NanoDrop 8000 microvolume UV--vis spectrophotometer (Thermo Scientific, U.S.A.).

Enzymatic Activity Assays {#sec4.7}
-------------------------

The concentrations of the purified enzymes were determined by Thermo Scientific NanoDrop 8000 (Thermo Fisher Scientific, U.S.A.). Meanwhile, a mix of 10 mM [l]{.smallcaps}-Pro, 1.5 mM FeSO~4~, 10 mM [l]{.smallcaps}-ascorbic acid, 10 mM 2-OG, and 150 mM 2-(*N*-morpholino)ethanesulfonic acid (MES) buffer (pH 6.5) was incubated in a Thermomixer Comfort incubator (Eppendorf, Hamburg, Germany) at 30 °C, 500 rpm. The reaction was started by adding 1 g·L^--1^ purified enzyme in a final volume of 500 μL.^[@ref36]^ Samples were taken 0, 5, and 10 min after adding the enzyme and analyzed by HPLC.^[@ref33]^ One unit of enzymatic activity was defined as the amount of enzyme required to catalyze the synthesis of 1 μmol *trans*-4-Hyp/min under standard conditions.

Determination of Kinetic Parameters {#sec4.8}
-----------------------------------

The kinetic parameters (*K*~m~ and *V*~max~) were determined in the assay mixture in a final volume of 300 μL. For [l]{.smallcaps}-proline, the standard assay conditions were used, with the concentration of [l]{.smallcaps}-proline ranging between 0.1 and 5 mM. Likewise, the concentration of 2-OG, where applicable, varied between 0.1 and 5 mM. The assays were carried out in triplicate. *Ka*PH1 activity was measured as described above, and the kinetic parameters were fitted into a Michaelis--Menten model.^[@ref37]^

Effects of pH and Temperature on *Ka*PH1 Activity {#sec4.9}
-------------------------------------------------

To determine the effect of pH, we measured *Ka*PH1 activity at a pH range of 4.0--9.0 with the standard reaction mixture. The effect of temperature on *Ka*PH1 activity was determined with the standard reaction mixture incubated for 10 min at different temperatures ranging from 10 to 45 °C.

Effects of Common Enzymatic Cofactors and Inhibitors on *Ka*PH1 Activity {#sec4.10}
------------------------------------------------------------------------

The effects of commonly found enzymatic cofactors ([l]{.smallcaps}-ascorbic acid, 2-OG, Mn^2+^, Mg^2+^, Co^2+^, Zn^2+^, Cu^2+^, and Ni^2+^), a divalent cation chelator (EDTA), a metal chelator (1,10-phenanthroline), and a nuclease inhibitor (diethyl pyrocarbonate) on *Ka*PH1 activity were investigated in the enzymatic activity assay system. *Ka*PH1 activity was measured as described above.

[l]{.smallcaps}-Proline Hydroxylation by *Ka*PH1 {#sec4.11}
------------------------------------------------

[l]{.smallcaps}-proline hydroxylation by the recombinant *Ka*PH1 was investigated under different substrate concentrations. The reaction mixture contained 1.5 mM FeSO~4~, 10 mM [l]{.smallcaps}-ascorbic acid, 10--120 mM [l]{.smallcaps}-proline, 10--120 mM 2-OG, 1 g·L^--1^ purified enzyme, and 150 mM MES buffer (pH 6.5) in a final volume of 500 μL. This mixture was incubated in a Thermomixer Comfort incubator (Eppendorf, Hamburg, Germany) at 30 °C, 500 rpm. Notably, [l]{.smallcaps}-proline and 2-OG were used at the same concentration.

Analytical Methods {#sec4.12}
------------------

The analyses of amino acids were carried out by the post column derivatization method with Fmoc-Cl.^[@ref33]^ The samples containing hydroxyproline were analyzed by using the Waters 2695 HPLC system equipped with a Diomansil C18 column (250 mm long with 4.6 mm in inner diameter). The chromatographic conditions were as follows: mobile phase A \[NaAc--HAc buffer (50 mM, pH 4.2):acetonitrile, 70:30\] and mobile phase B \[NaAc--HAc buffer (50 mM, pH 4.2):acetonitrile, 30:70\] were used with a gradient elution program at a flow rate of 1 mL·min^--1^, and the column temperature was kept at 25 °C. The injection volume was 10 μL. Fmoc-Cl derivatives of amino acids and hydroxyl amino acids formed in the reaction mixture were detected spectrofluorometrically at 263 nm.

LC--MS analysis was carried out using a Waters ACQUITY UPLC--MS system with a Waters ACQUITY UPLC HSS C18 reversed phase column (inner diameter: 1.8 μm). The inlet, MS transfer line, and ion source temperatures were set at 280, 280, and 230 °C, respectively.

Nuclear Magnetic Resonance (NMR) Analysis {#sec4.13}
-----------------------------------------

The products derived from [l]{.smallcaps}-proline hydroxylation by purified enzyme *Ka*PH1 were isolated from the reaction mixtures by the methods reported previously.^[@ref38]^ After the cation exchange chromatography using a strong cation resin (C100E (Na^+^ form), Purolite, England), the fractions with NH~4~OH were concentrated under vacuum. The reactions generated 2.13 mM *trans*-4-Hyp with 69% isolated yield. The concentrated product was dissolved in D~2~O, and then ^1^H NMR (400 MHz) and ^13^C NMR (100 MHz) analyses of the *trans*-4-Hyp were recorded using an Avance 400 (Bruker, Billerica, MA, U.S.A.). The chemical shifts were provided in parts per million, and coupling constants were reported in Hertz (Hz). Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br (broad). ^1^H NMR of *trans*-4-Hyp: 4.60 (s, 1H), 4.28 (d, *J* = 2.0 Hz, 1H), 3.40 (d, *J* = 3.7 Hz, 1H), 3.34--3.21 (m, 1H), 2.35 (d, *J* = 8.0 Hz, 1H), 2.09 (s, 1H). ^13^C NMR of *trans*-4-Hyp: 174.23 (s), 70.07 (s), 59.88 (s), 52.97 (s), 37.44 (s). The spectrum of the prepared *trans*-4-Hyp is consistent with that reported in the literature.^[@ref39]^

4-Hydroxyisoleucine (4-HIL) was generated in vitro by *Ka*PH1-mediated hydroxylation of [l]{.smallcaps}-isoleucine. The reactions generated 0.97 mM 4-HIL with 47% isolated yield. The spectrum of 4-HIL was recorded on an Avance 400 (Bruker, Billerica, MA, U.S.A.) at 400 MHz (^1^H NMR) as described before.^[@ref28]1^H NMR of 4-HIL: δ 3.84 (d, *J* = 4.4 Hz, 1H), 3.79 (dd, *J* = 13.6, 6.8 Hz, 1H), 1.92--1.82 (m, 1H), 1.19 (d, *J* = 6.3 Hz, 3H), 0.91 (d, *J* = 7.1 Hz, 3H).

Homology Modeling and Molecular Docking {#sec4.14}
---------------------------------------

Homology structures of *Ka*PH1 and P4H were constructed with Phyre 2^[@ref40]^ (PDB: 5NCI) as a template. All docking calculations of 2-OG and substrate [l]{.smallcaps}-proline were achieved with AutoDock 4.2.^[@ref41]^ Rigid receptor--flexible ligand docking was carried out with the standard parameters for interactive growing and subsequent scoring.
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